Dr. Panos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 Piedmont Avenue
Suite 4000
Cincinnati, OH 45219Phone+1 513-475-8523Fax+1 513-475-7327
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990
- University of MarylandResidency, Internal Medicine, 1983 - 1987
- The Warren Alpert Medical School of Brown UniversityClass of 1983
Certifications & Licensure
- OH State Medical License 2004 - 2026
- PA State Medical License 1997 - 2004
- IL State Medical License 1991 - 1999
- CO State Medical License 1990 - 1993
- MD State Medical License 1986 - 1987
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
- Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- 28 citationsHigh prevalence of chronic obstructive pulmonary disease among veterans in the urban midwest.Daniel E. Murphy, Zeshan Chaudhry, Khalid F. Almoosa, Ralph J. Panos
Military Medicine. 2011-05-01 - 11 citationsVeterans with chronic obstructive pulmonary disease achieve clinically relevant improvements in respiratory health after pulmonary rehabilitation.Stephen Major, Marcella Moreno, John Shelton, Ralph J. Panos
Journal of Cardiopulmonary Rehabilitation and Prevention. 2014-11-01 - 128 citationsOxygen Therapy for Patients With COPD: Current Evidence and the Long-Term Oxygen Treatment TrialJames K. Stoller, Ralph J. Panos, Samuel L. Krachman, Dennis E. Doherty, Barry J. Make
Chest. 2010-07-01
Press Mentions
- Arch Biopartners’ Therapy Candidate AB569 Receives US Patent for Treatment of Chronic Lung InfectionsApril 6th, 2018
- Veterans Affairs Hospital Introduces New Tele-ICU TechnologyMarch 28th, 2018
- Arch Biopartners’ Lead Anti-Bacterial Drug Candidate AB569 to Enter Investigator-Sponsored Phase I Human TrialApril 13th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: